ArticleBMC public health2025

Safety of sinopharm COVID-19 vaccine in children and adolescents aged 5 to 18 years: a cohort event monitoring study.

Mohammad Hassan Emamian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.